Full Title
Phase 2 Trial of Elranatamab with Cyclophosphamide in Relapse/Refractory Multiple MyelomaPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Alexander Lesokhin’s office at 646-608-3717.
Protocol
26-006
Phase
Phase II (phase 2)
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07454382
ClinicalTrials.gov